Agena Bioscience enables laboratories worldwide to deliver
affordable targeted genetic testing.
Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.
Using as little as 1.5 µL of cfDNA, the LiquidIQ™ Panel determines the total number of amplifiable copies present in the sample. In addition, it can also estimate the amount of WBC contamination and identify the presence of long DNA fragments.Learn More
Common CYP2D6 genotyping and copy number detection methods cannot detect these alleles, resulting in pharmacogenetic profile mischaracterization. Dr. Houda Hachad offers recommendations for overcoming this challenge.View Webinar Recording
Date: 16 May 2019 - 18 May 2019
Location: Hong Kong
Date: 23 September 2019 - 27 September 2019
Location: Pittsburgh, PA, United States
23 October 2018
21 August 2018